Lindsey Shapiro, PhD, science writer —

Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.

Articles by Lindsey Shapiro

Dazodalibep’s Benefits Seen In 2nd Sjögren’s Patient Group

Investigational therapy dazodalibep significantly eased symptom burden in people with Sjögren’s syndrome who have moderate-to-severe symptoms, but minimal systemic disease activity, meeting the goal of Horizon Therapeutics‘ Phase 2 clinical trial. Horizon previously announced the trial also met its other main goal of reducing disease activity in…

Biomarkers of Interstitial Lung Disease in Sjögren’s Syndrome Identified in Study

Age, disease duration, and blood levels of inflammatory markers Krebs von den Lungen-6 (KL-6) and TNF-alpha are the most discriminating factors for identifying Sjögren’s syndrome patients with interstitial lung disease, a study found. While less significantly associated, other inflammatory markers, including immunoglobulin M (IgM), c-reactive protein (CRP), eotaxin, and…